• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 97 of 100
PA: Mylan Headquarters
Finance
Mylan goes big with $29 billion offer to buy Perrigo
By Laura LorenzettiApril 8, 2015
Pneumococcus Vaccine
Pfizer to stop selling vaccines in China after failing to get license renewal
By Reuters and Fortune EditorsApril 2, 2015
IL: Corporations In Illinois
Features
Takeda’s ready to shell out $2.2 billion to settle Actos drug cases
By Laura LorenzettiApril 1, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
Retail
J&J, Glaxo settle U.S. lawsuit over allergy ads
By ReutersMarch 30, 2015
First Day Of Trading For 2012 At The NYSE
Finance
Dow gains 260 points as stock market jumps on news out of China
By Tom Huddleston Jr.March 30, 2015
Lincoln Continental To Be Phased Out
Features
Greece tries again and Ford brings back the Lincoln Continental — 5 things to know today
By Laura LorenzettiMarch 30, 2015
Walgreens workers no longer want you to ‘Be Well’
Retail
Walgreens workers no longer want you to ‘Be Well’
By Ben GeierMarch 26, 2015
Where do CEOs with addictions go when they hit bottom?
Leadership
Where do CEOs with addictions go when they hit bottom?
By Daniel BukszpanMarch 25, 2015
Merck
Features
Merck halts study in light of melanoma drug’s success
By Laura LorenzettiMarch 24, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features
Novartis unit hit with $110 million gender discrimination suit
By ReutersMarch 17, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By Laura LorenzettiMarch 16, 2015
FRANCE-HEALTH-ALLERGIES-POLLEN
Retail
Spring must be here! J&J sues Glaxo over allergy cure claims
By Geoffrey SmithMarch 13, 2015
Stefano Pessina, Executive Deputy Chairm
Retail
Is Walgreens about to go shopping again?
By Reuters and Fortune EditorsMarch 12, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., speaks during their annual general meeting in Laval, Quebec
Finance
Endo International makes competing bid for Salix Pharmaceuticals
By ReutersMarch 11, 2015
Biotech pros’ top 8 stock picks
Tech
Biotech pros’ top 8 stock picks
By Jen WiecznerMarch 9, 2015
1...
  • 95
  • 96
  • 97
  • 98
  • 99
100
Most Popular
Personal Finance
Social Security has less than 6 years before a 22% cut. A Senate chairman’s fix is to borrow $190 trillion and call it the ‘Stop Scaring Seniors Act’placeholder alt text
By Nick LichtenbergNovember 19, 2026
Big Tech
Sound Ventures turned $435 million into a $7 billion Anthropic stake. Ashton Kutcher left months before the IPOplaceholder alt text
By Steven JohnNovember 19, 2026
Cybersecurity
‘This, I’m sorry to say, is just the opening chapter’: Top cyber expert warns of a ‘vulnpocalypse’ after 4 major U.S. systems broke in 6 daysplaceholder alt text
By Nick LichtenbergNovember 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.